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SUMMARY 
 
 
Several epidemiological studies indicate that there is a correlation between air pollution and 
diesel exhaust, and increased risk of lung cancer. In this study we have evaluated and 
compared the effects from different nitro-polycyclic aromatic hydrocarbons (nitro-PAHs), 
which are mutagenic and carcinogenic. In diesel exhaust we find both PAHs and nitro-PAHs, 
of which some are classified as mutagenic and carcinogenic. The mouse hepatoma cell line 
Hepa1c1c7 and human bronchial cell line BEAS-2B were exposed to 1-nitropyrene (1-NP), 
1.3-dinitropyrene (1.3-DNP) and 1.8-dinitropyrene (1.8-DNP). The compounds lead to both 
apoptosis and necrosis cell death in Hepa1c1c7, however, no major effect where found in 
BEAS-2B besides that 1-NP caused a small increase in release of the cytokine CXCL8 (IL8). 
After examination in the Hepa1c1c7 cells it was clear that 1.3-DNP was the most cytotoxic, 
followed by 1-NP. 1.8-DNP caused a delayed cell death as determined by fluorescence 
microscopy after longer exposure. 1.3-DNP did show, after western blotting, a cleavage of 
caspase 3 and PARP indicating that cells die from an apoptotic process, in addition the 
inhibitor zVAD-FMK did show a partly inhibition of the cell death, indicating that there is 
need for caspase activation, but also that there is a parallel pathway. Flow cytometric analysis 
showed a shift in cell cycle. Exposure to 1-NP and 1.3-DNP caused the cells to accumulate in 
G2-phase, whereas 1.8-DNP caused an accumulation of cells in S-phase. A reason for the shift 
in cell cycle can be that the DNA is damaged. Little DNA single strand breaks (SSB) were 
seen after analysing comet assay using standard condition. With modification to detect 
oxidized purines and alkali labile sites, however, there were a great increase in the response. 
Further investigation of the DNA damage response (DDR) shows that 1.8-DNP activates both 
H2AX, p53 and Chk1, however, NOXA did not show any upregulation. Activation of p53 by 
1.8-DNP showed a translocation, which is in contradiction to our last study. p53 inhibition 
after 1.3-DNP exposure by pifithrin-α,  did fully reduce the amount of cell death, indicating 
that signalling and activation of p53 is important in the cell death. In contrast, pifithrin-µ gave 
no reduction in cell death, supporting that it is the transcriptional activity of p53 that is needed 
to execute the cell death. The study illustrates that a change in conformation by nitro-group 
gives a dramatic change in cytotoxicity. Although a p53 transcriptional activity is needed, 
possibly also other signalling pathways are involved in the triggering of cell death.  
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ABBREVATIONS 
 
 
AhR, aromatic hydrocarbon receptor; BEAS-2B, Human bronchial epithelia cell line; 
CXCL8, IL-8 (interleukin 8); DMSO, dimethyl sulfoxide; ELISA, Enzyme-Linked 
ImmunoSorbent Assay; 1-NP, 1-nitropyren; 1,3-dNP, 1,3-dinitropyren; 1,8-dNP, 1,8-
dinitropyren; Chk, checkpoints; DDR, DNA damage response; nitro-PAH, nitro substituted-
polycyclic aromatic hydrocarbons; γH2AX, phosphorylated H2A.X; Hoechst 33258, 2(2-(4-
hydroxyphenyl)-6-benzimidazole-6-(1-methyl-4-piperazyl)benzimidazole hydrochloride); 
Hoechst 33342, 2´-(4-ethoxyphenyl)-2´,5´-bis-1H-benzimidazole hydrochloride); PAH, 
polycyclic aromatic hydrocarbon; PARP, poly(ADP-ribose) polymerase; PI, propidium 
iodide; PFT, pifithrin; SSB, single strand breaks; zVAD-FMK, benzyolcarbonayl-Val-Ala-
Asp-fluoromethyl ketone.  
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 1. BACKGROUND 
 
1.1 Introduction 
 
Sources and health effects of air pollutants 
A number of natural (volcanoes, fire, etc.) and/or anthropogenic activities can result in 
environmental pollutants. By definition, an air pollutant is any substance which may harm 
humans, animals, vegetation or material. Particulate matter (PM) is the generic term used for a 
type of air pollutants, consisting of complex and varying mixtures of particles suspended in 
the breathing air, which vary in size and composition, and are produced by a wide variety of 
natural and anthropogenic activities (Kampa and Castanas 2008; Air quality guidelines for 
Europe  2000). 
 
Engine exhausts contain thousands of gaseous and particulate substances. Internal combustion 
engines have been used in cars, trucks, locomotives and other motorized machinery for about 
100 years. Particles emitted from engines operating with diesel are different from gasoline, in 
terms of their size distribution and surface properties. Diesel engines produce two to 40 times 
more particulate emissions and 20-30 times more nitroarenes than gasoline engines with a 
catalytic converter in the exhaust system, when the engines have similar power output (IARC 
monographs on the evaluation of carcinogenic risks to humans. Diesel and gasoline engine 
exhausts and some nitroarenes. International Agency for Research on Cancer  1989). As more 
knowledge has been discovered regarding emissions and the hazardous effects it can give 
several measures has been taken to reduce the emission. Various techniques can be used to 
minimize emission like engine maintenance, exhaust filtration and use of reformulated fuels 
(Volkwein et al. 2008). Today there are advanced three-way catalysts systems in engines 
resulting in exceptionally low emissions (Twigg 2005).    
 
Exposure to diesel exhaust and urban air pollution have shown association with an increased 
risk of lung cancer in epidemiological studies (Arlt 2005). However negative association with 
air pollution is not a new phenomenon. Percival Pott saw a connection between cancer of the 
scrotum and testicles and exposure to soot already in 1775 (Brown and Thornton 1957). It 
was proven, in 1875 by von Volkman, that industrial tar, coal tar, and crude paraffin caused 
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skin cancer (Hajdu 2006; Guengerich 2005). The first episode that leads to scientific proof of 
the potential for atmospheric pollution to cause deaths and disease was not the London fog of 
December 1952, but the fog that affected the Meuse Valley in Belgium in December 1930. 
Between December 1 and December 5 a thick fog covered Belgium. From December 3 
hundreds of people in the villages in the narrow part of the valley started to have severe 
respiratory signs and symptoms, and more than 60 people died during the next three days 
(Nemery, Hoet, and Nemmar 2001). The Great Smog of December 1952, in London, that 
lasted 5 executive days, from December 5 to December 9, were caused by atmospheric 
conditions, with a lack of wind and a layer of cold air overlaid by warm air. This smog, that 
was particulate based, were estimated to have killed about ca 4000 lives, and an additional 
estimate of 8000 during the 10 weeks that followed (Black 2003; Schwartz 1994; Bell and 
Davis 2001). Smog is made up of the words smoke and fog and is a mixture of possibly 
hundreds of pollutants, some in their original state and some converted as a result of chemical 
reactions occurring with sunlight, ozone, oxides of nitrogen and other factors in the 
atmosphere (Bryan 1954). This phenomenon can be seen in many major cities like New York, 
Los Angeles, Beijing and Tokyo (Senn 1948).  
 
The primary components to air pollution are sulphurdioxide (SO2), nitrogen oxides (NOx), 
carbonmomonoxide (CO), ozon (O3) and suspended dust (Brook et al. 2004). Usually particle 
matter (PM) is described as mass (weight) per volume unit air, for example µg/m
3
, and the 
particles are described by their aerodynamic diameter. The aerodynamic diameter is 
somewhat different than geometric diameter and is the theoretical diameter to a spherical 
particle with net weight 1 and will fall as fast in air as the real particle. Different net weight 
give different aerodynamic diameter to particles that are geometric identical (Ormstad and 
Lovik 2002). PM10 (AD < 10 µm) thoracic particles, PM10 to 2.5 coarse particles, PM2.5 (AD < 
2.5 µm) fine particles and PM0.1 (AD < 0.1 µm) ultrafine particles, this is one way to 
categorize particulate matter regarding size. Greater particles deposit more often in the upper 
trachobronchial regions, whereas smaller particles show greater deposition in the deep lung 
(Brook et al. 2004).   
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Figure: Illustration of the different sizes of the particle fractions. The coarse fraction has the same size as a 
cell, the fine particles as bacteria and the ultrafine particles like virus and molecules. The illustration is from 
Brook and colleagues. (Brook et al. 2004) 
 
Urban outdoor air pollution is described in an article in Lancet in 2002 as major cause of 
mortality due to combined respiratory and selected cardiovascular causes (Ezzati et al. 2002). 
Several epidemiological studies have shown negative health effects related to air pollution. 
The most important sources of particulate matter is diesel exhaust and particles from road dust 
and wood fuel (Ormstad and Lovik 2002). Inhalation of airborne particles has been 
recognized and documented as a high health risk. And epidemiological studies have shown 
associations between exposure to particulate matter in the air and increases in morbidity and 
mortality. Size has also been highlighted as nanoparticles have increased specific toxicity 
relative to larger particles composed of the same materials (Gorbunov et al. 2009).  
 
1.2 Diesel exhaust 
 
Diesel exhaust particles are mainly composed of nano-sized particles (Hesterberg et al. 2010). 
The largest single source of airborne PM from vehicles is derived from diesel exhaust (Riedl 
and Diaz-Sanchez 2005). The particles in diesel motor emissions are composed of a center 
core of elemental carbon and adsorbed organic compounds as well as small amounts of 
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sulfate, nitrate, metals, and other trace elements. Diesel particulate matter consists of fine 
particles and a high number of ultrafine particles. Their small size makes them highly 
respirable and they have the potential to reach the deep lung. Diesel motor emission include 
both polycyclic aromatic hydrocarbons (PAHs) and nitro-PAHs (Wichmann 2007). Diesel 
exhaust particles are the major component of PM2.5 in urban areas (Kawasaki et al. 2001). 1-
NP has been recognized as an environmental carcinogen of concern to humans and one of the 
major genotoxic components of diesel exhaust particles (Hatanaka et al. 2001).  
 
Since the 1970s, there has been concern that inhalation of diesel exhaust may cause lung 
cancer in humans (Garshick et al. 2004). Now, epidemiological studies have found an 
elevated risk of lung cancer among truck drivers when they were regularly exposed to diesel 
exhaust, for example among short distant lorry drivers in the urban areas of Sweden (Garshick 
et al. 2008; Jakobsson, Gustavsson, and Lundberg 1997).  
 
1.3 Polycyclic aromatic hydrocarbons and nitro PAHs. 
 
PAHs, polycyclic aromatic hydrocarbons, are organic compounds with at least two aromatic 
rings fused together. They are formed primarily as a result of incomplete combustion of fossil 
fuels and other organic materials. Other sources contributing to production of PAHs are 
smoking, burning wood in indoor stoves, car- and air traffic and barbecuing. PAH compounds 
were one of the first pollutants to be identified as human carcinogens (Zhu et al. 2011; Overall 
evaluations of carcinogenicity: an updating of IARC Monographs volumes 1 to 42  1987). 
The best studied of the various PAHs is benzo[a]pyrene (B[a]P), it is categorized as a group 
2B carcinogen by IARC (IARC monographs on the evaluation of carcinogenic risks to 
humans. Diesel and gasoline engine exhausts and some nitroarenes. International Agency for 
Research on Cancer  1989). 
 
Nitro-polycyclic aromatic hydrocarbons (nitro-PAH) 
A nitro-PAH is build up one or more nitro groups (-NO2) attached to a polycyclic aromatic 
hydrocarbon. Nitroaromatic compounds can form naturally in both atmospheric and aqueous 
environments, it is shown that polycyclic aromatic hydrocarbons react with oxides of nitrogen 
to form nitroaromatics under conditions that might be expected in polluted air and in 
combustion processes (Purohit and Basu 2000). In urban settings, hydrocarbons released from 
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natural combustion processes and the incomplete combustion of fossil fuels serve as 
substrates for nitration with atmospheric nitrogen dioxide (Ju and Parales 2010). The 
nitropyrenes are common environmental pollutants. 1-NP is one of the major mutagenic 
components of diesel particulates, whereas the dinitropyrenes (DNPs) are present in much 
lower concentrations. 1-NP accounts for approximately 25% of the mutagenicity of diesel 
emissions (Purohit and Basu 2000).  By undergoing substitutions reactions PAHs can rapidly 
form nitro-PAHs. Nitro-PAHs are of concern because they can direct acting as mutagens and 
carcinogens (Yaffe et al. 2001). Nitro-PAHs require metabolic activation in order to exert 
their genotoxic activities (Fu et al. 1994). Oxidation and reduction products of nitroaromatic 
compounds can damage DNA directly or cause the formation of adducts that induce 
mutagenesis by misincorporation of nucleotides during DNA synthesis. Structural and 
spectroscopic studies have found that the position of the nitro group on the aromatic ring and 
the presence of other functional groups can influence the mutagenicity and carcinogenicity of 
these chemicals. Factors that can contribute to covalent binding to DNA include 
hydrophobicity, metabolism, ability to intercalate, orientation prior to binding and DNA 
sequence specificity of binding. Additional, factors that contribute to the mutagenicity of the 
adduct formation induced by the activated compounds are DNA-bound confirmation, 
interactions with DNA polymerases and repair proteins, and effect of DNA sequence.  
(Purohit and Basu 2000; Ju and Parales 2010).  
 
The different PAHs used in this study are illustrated in this figure: 
 
1.4 Metabolism 
 
The biological activities of PAHs rely on different properties. PAHs can metabolically be 
converteted to reactive electrophilic intermediates that can covalently bind nucleophilic 
Benzo[a]pyrene 
(B[a]P) 
 
1-nitropyrene 
(1-NP) 
 
1.3-dinitropyrene 
(1.3-DNP) 
 
1.8-dinitropyrene 
(1.8-DNP) 
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targets in DNA, RNA and proteins. This is why adducts will be formed in DNA and 
mutations will be induced that can eventually lead to tumors. Reactive metabolites can also be 
formed; these can react with other cellular targets and interfere with transcription, DNA 
replication, and protein synthesis. In addition, some PAHs can, after metabolism induce 
inflammatory processes (Bostrom et al. 2002). Nitro-PAHs can be biotransformed by CYP 
enzymes, nitroreductases and phase II biotransformation enzymes. The location of the nitro 
group on the aromatic system is crucial since it affects metabolism and DNA binding 
properties (Chae et al. 1999; Purohit and Basu 2000). Nitro-PAHs require metabolism to form 
reactive electrophilic species in order to exert their genotoxic activity (Arlt 2005). 1-NP is 
classified as possibly carcinogenic to humans (class 2B) by The International Agency for 
Research on Cancer (Hatanaka et al. 2001). Nitro-PAHs are metabolized via nitroreduction 
and P450-mediated C-oxidation (Yamazaki et al. 2000). Reduction of nitroaromatic 
compounds occurs by one- or two-electron reductive pathways. This can lead to the 
corresponding amine (R-NH2) and generates electrophilic reactive intermediates (nitroso and 
hydroxyamino) or reactive oxygen species depending of the nitroreductase (NR) involved in 
the process and the availability of oxygen. There are two types of NR, type I (oxygen 
insensitive) proceeds with two-electron reduction. In contrast, type II (oxygen-sensitive) 
catalyzes one-electron reduction, generating the corresponding nitro anion radical 
intermediate that can be oxidized back to the parent nitro compound in the presence of 
molecular oxygen (Ask et al. 2004). When the redox cycle take place and regeneration of the 
nitro compound and production of superoxide anion take place, then dismutation yields 
hydrogen peroxide. Therefore, reduction of some nitroaromatic compounds can lead to the 
formation of reactive intermediates and/or potentially toxic reactive oxygen species (Ask et al. 
2003).  
When nitroarenes bind covalent to macromolecules nitro reduction is the first important step 
that takes place, this is an N-directed metabolic activation. The nitro group can either be 
partially reduced to form a nitroso or an N-hydroxyl intermediate or be completely reduced to 
an amine (Scheepers et al. 1994).  
 
 
Cancer – inflammation, cell death and DNA-damage. Chronic inflammatory processes can 
induce oxidative stress. This makes a continuous and self-perpetuating production of excess 
ROS among other. Cellular DNA, RNA and proteins can then be damaged by reactions, such 
as oxidations, nitration, nitrosation, halogenation, and exocyclic ring formation in nucleic acid 
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bases. Inhibition of DNA repair enzymes and blockage of proapoptotic pathways may occur. 
This leads to increased genetic changes and altered functions of important proteins with 
ensuing deregulation of cell homeostasis, facilitating the initiation normal cells, their growth, 
and progression to malignancy (Bartsch and Nair 2006).  
 
1.5 Cell death 
 
Cell death and survival is essential for cell differentiation, and to maintain homeostasis 
(Nicotera et al. 2007). Cell death, and especially apoptosis act as a barrier to cancer, this was 
first raised in 1972 by Kerr, Wyllie and Currie. Loss of the tumor suppressor gene p53 is seen 
in greater than 50% of human cancers, and is a key component of the DNA damage sensor 
that can induce apoptosis (Hanahan and Weinberg 2000). Also in development we encounter 
cell death, apoptosis is a major form of cell death that is used to remove excess, damaged or 
infected cells throughout life (Bratton and Cohen 2001). Cell death is important in many other 
parts of life, but also in disease we encounter cell death. Both too much cell death, like in 
neurodegenerative diseases e.g. Parkinson and Alzheimer, and too little, e.g. development of 
cancers can be hazardous but for different reasons.  
 
1.5.1 Permanent cell cycle arrest (senescence) 
The term senescence is derived from the Latin word senex, meaning ”old age” or ”advanced 
in age”. Senescence at the cellular level is a physiological program of cellular growth arrest 
that is triggered by the shortening of telomers or by stress (Singh, George, and Shukla 2010). 
Senescent cells display phenotypic alterations that include a permanent growth arrest. This 
arrest typically occurs in the G1 phase of the cell cycle and is often accompanied by 
expression of senescence associated β-galactosidase (SA-β-gal) activity. Senescent cells 
undergo gene expression alterations, including increased expression of cell cycle inhibitors 
such as p21 and p16 and down regulation of cell cycle proteins. Despite lack of proliferation 
these cells are metabolic active and may secrete proteins with tumor-promoting activities. 
Cellular senescence is a potent anti-cancer mechanism controlled by tumor suppressor genes, 
particularly p53 and pRb. P53 gets activated upon genotoxic and non genotoxic stresses like 
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oxidative damage and activated p21 and ultimately culminates the cell to senescence (Singh, 
George, and Shukla 2010)  (Pazolli and Stewart 2008). 
 
1.5.2 Autophagy 
In Greek autophagy means self-eating (Gozuacik and Kimchi 2004). Autophagy is a tightly 
regulated pathway involving the lysosomal degradation of cytoplasmic organelles or cytosolic 
components. This catabolism enables recycling to maintain nutrient and energy homeostasis. 
This pathway can be stimulated by multiple form of cellular stress, including nutrient or 
growth factor deprivation, hypoxia, reactive oxygen species, DNA damage, protein 
aggregates, damaged organelles, or intracellular pathogens. (Kroemer, Marino, and Levine 
2010). Autophagy as also been linked to cell death, innate immunity, adaptive immunity, and 
tumor genesis. Morphologically, autophagic cell death is defined by the massive cytoplasmic 
accumulation of autophagocomes in dying cells without chromatin condensation, the hallmark 
of apoptosis (Malhi, Guicciardi, and Gores 2010). 
 
1.5.3 Mitotic catastrophe 
Mitotic catastrophe (MC) is a type of cell death that results from premature or inappropriate 
entry of cells into mitosis and can be caused by chemical and physical stresses.  Mitotic 
catastrophe can be looked at as a process (prestage) preceding cell death, which can occur 
through necrosis or apoptosis. The final outcome of MC depends of the molecular profile of 
the cell. 
  
The term ”mitotic catastrophe” is used to explain a mechanism of a delayed mitotic-linked 
cell death.  The G2 checkpoint of the cell cycle is responsible for blocking mitosis when DNA 
of cells is exposed to sustained insults. DNA damage activates a number of molecules that 
promote cellular activities such as cell-cycle arrest, DNA repair or apoptosis, if the damage is 
too harsh to be repaired. If the G2 checkpoint is defective a cell can enter mitosis prematurely, 
before DNA replication of complete or DNA damage is repaired. This aberrant mitosis causes 
the cells to undergo death by mitotic catastrophe. The final step of MC is almost always 
characterized by the formation of nuclear envelopes around individual clusters of 
missegregated chromosomes. MC is also correlated with incomplete DNA synthesis and 
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premature chromosome condensation (Vakifahmetoglu, Olsson, and Zhivotovsky 2008; Jin 
and El-Deiry 2005). 
 
1.5.4 Necrosis 
Necrosis is thought to represent an accidental from of cell death with simultaneous disruption 
of multiple pathways. However, extensive failure of normal physiological pathways that are 
essential for maintaining cellular homeostasis, such as regulation of ion transport, energy 
production and pH balance can lead to necrosis .Necrosis is derived from the Greek “necros” 
for corpse and is characterized by oncosis (Greek for swelling) and the formation of plasma 
membrane blebs. There is also a lack of apoptotic markers like chromatin condensation or 
nucleosomal-sized DNA fragmentation. A cellular feature of necrosis is rupture of the plasma 
membrane, which leads to the release of cellular contents that can stimulate inflammation and 
damage surrounding cells. Other markers for necrosis are ATP depletion, excessive formation 
of reactive oxygen species and sustained increases in intracellular calcium. Necrosis can be 
triggered as a direct result of “extrinsic” stimulation by death cytokines in the TNF 
superfamily or by “intrinsic” signals such as DNA damage. Recently a new way of 
categorizing necrosis have also been used, necroptosis, as it too seems to have its own set of 
pathways steps (Challa and Chan 2010; Malhi, Guicciardi, and Gores 2010; Jin and El-Deiry 
2005). 
 
1.5.5 Apoptosis 
Apoptosis is derived from a Greek word that describes “leaves falling from a tree”; it is used 
to define a specific morphological aspect of cell death characterized by membrane blebbing, 
shrinkage of the cell, chromatin condensation, and nuclear fragmentation, followed by 
scission of the cell into membrane defined bodies termed apoptotic bodies. Apoptosis is 
usually initiated and executed by activation of intracellular enzymes termed caspases as a 
contraction for cysteine-dependent aspartate specific protease. Caspases are synthesized as 
zymogens that must undergo proteolytic cleavage to exert proteolytic activity. Executioner 
caspases such as caspases 3, 7 and 6 are activated by cleavage by initiator caspases at 
aspartate residues and can be activated by either death receptor or mitochondrial pathways of 
apoptosis. These caspases may activate caspase-activated DNase (CAD) by cleaving ICAD, 
an inhibitor of this enzyme. CAD activation results in DNA cleavage at internucleosomal 
16 
 
linker regions of DNA resulting in the ladder pattern of DNA cleavage thought to be 
characteristic of apoptosis   (Malhi, Guicciardi, and Gores 2010).  
 
Apoptosis is a non-inflammatory form of cell death because apoptotic cells display “eat-me” 
signals such as phosphatidylserine on the cell surface early during the cell death process. This 
enable fast clearance of apoptotic cells by phagocytes before they can release cellular 
adjuvants to the environment and trigger an inflammatory response (Challa and Chan 2010). 
 
Apoptosis is an essential part of life for multicellular organisms that plays an important role in 
development and tissue homeostasis. During development many cells are produced in excess 
which eventually undergo programmed cell death and thereby contribute to sculpturing organs 
and tissues (Jin and El-Deiry 2005). The term programmed cell death is often used in the 
literature, this refers to a genetically controlled process (Malhi, Guicciardi, and Gores 2010). 
There are to major apoptotic pathways; the extrinsic pathway (death receptor pathway) or the 
intrinsic pathway (the mitochondrial pathway) within a cell. The extrinsic pathway is 
activated by apoptotic stimuli comprising extrinsic signals such as the binding of death 
inducing ligands to cell surface receptors. Or, apoptosis is initiated following intrinsic signals 
including DNA damage induced by irradiation or chemicals, growth factor deprivation or 
oxidative stress (Jin and El-Deiry 2005; Clarke and Allan 2009).  
 
The extrinsic pathway is driven by signals from the outside of the cell that binds as a ligand to 
so-called death receptors (DSs) on the cell surface. The fas receptor is as such a death receptor 
and is a part of the tumor necrosis factor (TNF) family. Multimerization of trimeric receptors 
leads to direct or indirect recruitment of the adaptor protein FADD allowing for activation of 
initiator pro-caspase 8 and subsequent activation of effector caspase 3, 6a and 7 (Tischner et 
al. 2010).  
 
The intrinsic pathway, which leads to mitochondrial outer membrane permeabilization 
(MOMP) gives the release of apoptogenic factors from the inner-membrane space, most 
importantly cytochrome c, triggering oligomerization of the adapter molecule Apap-1, leading 
to recruitment and activation of initiator pro-caspase 9 molecules (Tischner et al. 2010). 
Caspase activation leads to the cleavage of cellular substrates and apoptosis. Bcl-2 family of 
proteins includes both pro- (Bax, Bak) as well as anti-apoptotic (Bcl-2, Bcl-xL) proteins 
(Gross, McDonnell, and Korsmeyer 1999). Bax has been shown to homodimerize as well as 
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heterodimerize with Bcl-2 to repress cell death. Bad heterodimerizes with Bcl-xL it displaces 
Bax from Bcl-xL and promotes cell death (Yang et al. 1995).  
 
1.6 Inflammation 
Inflammation is the response of an organism’s immune system to damage done to its cells and 
vascular tissue. It is usually a healing response, but can also proceed and become a chronic 
state (Weiss 2008). The inflammatory process includes a tissue-based reaction to trauma, 
go/no-go decision based on integration of molecular clue for tissue penetration by microbes, 
the killing of microbes and host cells they infect. Persistent inflammation can oxidize DNA 
severe enough to promote neoplastic transformation. The transformation from tissue damage 
to tissue repair begins as complement, neutrophils and macrophages kill microbes, and 
macrophages secrete more SLPI, a serine protease inhibitor expressed late after exposure to 
microbial products or cytokines (Nathan 2002).  
 
1.7 Cytokines  
An infection or injury will most likely cause an inflammation in the body. The recruitment of 
netrophiles to the site of injury is directed by chemotactic polypeptides, chemokines 
(Hoffmann et al. 2002). The chemokine family consists of approximately 50 small, basic 
proteins that are expressed and released by a wide range of normal and malignant cells. Based 
on their molecular structure these cytokines are divided into the two major subgroups CCL 
and CXCL chemokines that bind CCR or CXCR receptors respectively  (Singh et al. 2010; 
Olsnes, Hatfield, and Bruserud 2009). There is increasing evidence that many 
proinflammatory and anti-inflammatory cytokines may promote tumor progression and affect 
the antitumor response (Tsujimoto et al. 2010). Interleukin-8 (IL-8) is a multifunctional 
protein that acts as intercellular regulatory factor. It is produced by immunocompetent cells 
such as T lymphocytes and monocytes in local inflammatory tissue infiltrates. Perionontal 
tissue components such as fibroblasts and epithelial and endothelial cells also participate in 
cytokine formation during inflammatory responses. IL-8 has a proinflammatory function. In 
noninduced cells, IL-8 is barely secreted, but its production is rapidly induced by a wide range 
of stimuli. Some stimuli can up-regulate IL-8 by more than 100-fold (Hoffmann et al. 2002; 
Candel-Marti et al. 2011). 
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1.8 DNA-damage 
DNA lesions can be caused by either endogenous (reactive oxygen species (ROS) resulting 
from metabolic processes) or exogenous (ionizing radiation (IR), UV) agents, this happens 
frequently, approximately 10
4
 per cell per day. The repair pathway activated is dependent of 
the type of lesion created. Base excision repair (BER) and nucleotide excision repair (NER) 
pathways are typically activated in response to damage to individual DNA bases (Seviour and 
Lin 2010).  
 
1.9 DNA-damage response 
To overcome all the lesions formed on DNA, cells have complex damage detection and repair 
system. This system is termed the DNA damage response (DDR), and encompasses the 
recognition of DNA damage, the transduction of signals through appropriate pathways and the 
activation of cellular responses ranging from DNA repair and chromatin remodeling to the 
activation of cell death if the damage is irreparable (Seviour and Lin 2010).  
 
H2AX is a member of histone H2A family, which is one of the five types of histones that 
package and organize eukaryotic DNA into chromatin. The basic composition of chromatin is 
the nucleosome. Each nucleosome consists of eight histone molecules, two from each of the 
four core histones (H2A, H2B, H3 and H4) to form an octamer (Yuan, Adamski, and Chen 
2010). Upon induction of a DNA double-strand break (DSB), the H2AX omega-4 serine 
residue becomes rapidly phosphorylated to from gamma-H2AX (γ-H2AX). Phosphorylation 
of H2AX is carried out by one of three phospho-inositide-3-kinase-related protein kinases – 
ATM ATR or DNA-PK (Coster and Goldberg 2010).  H2AX has a role as a tumor suppressor 
(Dickey et al. 2009). H2AX is one of the most conserved H2A-variants and is present in 
chromatin at levels that vary between 2 and 25% of the H2A pool (Kinner et al. 2008). 
 
Chk1 and Chk2 are serine-threonine checkpoint kinases, and are considered to be the major 
effectors of the DDR in regulating cell cycle checkpoints. Chk1 and Chk2 are phosphorylated 
by ATR and ATM, respectively. They are effector kinases that regulate DNA-damage-
induced arrest at specific stages of the cell cycle by targeting key cell-cycle regulators. Chk1 
is essential for early embryonic development and the G2 checkpoint response to DNA damage 
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and replication block (Smits, Reaper, and Jackson 2006; Smith et al. 2010; Clarke and Allan 
2009).  
 
p53 is one of the best studied tumor suppressors. In more than 50% of human tumors it is 
mutated. It is a nuclear transcription factor that transactivate a variety of target genes 
implicated in the induction of cell cycle arrest (e.g. p21
waf
), regulatory functions (e.g.Mdm2), 
DNA repair, and apoptotic cell death (e.g. IGF-BP3, BAX). The activation domain is located 
at the N-terminus of the protein. This domain can interact with components of the basal 
transcription machinery and promote transcription of genes with p53 binding sites. When cells 
are unstressed the p53 level is kept low by the negative regulator of p53, Mdm2 (Zhang, Liu, 
and Wang 2011). In response to cellular stress, like DNA damage, it is activated, by 
phosphorylation, and promotes cell cycle arrest followed by the replacement of DNA lesions 
and/or apoptotic cell death (Ozaki and Nakagawara 2011; Mak 2011; Unger et al. 1999).  
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2. AIMS 
The objective with this study was to characterize the toxicity of the different nitro-PAHs in 
both the human bronchial epithelial cell line BEAS-2B and in the mouse hepatoma cell line 
Hepa1c1c7. From the first screening the focus were set to Hepa1c1c7 since the BEAS-2B 
gave little effect.  
 
Sub-goals: 
 
o To investigate the toxicity of the different nitro-PAH compounds, by studying the 
level of cell death (apoptosis and necrosis).  
 
o To investigate the compounds induce survival and death signals. 
 
o To study the compounds effect on cell cycle. 
 
o To investigate the compounds effect on DNA-damage and DNA-damage signaling. 
 
This master-thesis is a part of a larger project. Western analysis of Chk1, pp53 and NOXA 
was done by Leni Ekerheim at the National Health Institute, Division of environmental 
medicine,  
 
 
 
3. EXPERIMENTAL CONSIDERATIONS 
 
The experimental system BEAS-2B cells 
A transformed continuous cell line, BEAS-2B cells, derived from normal human bronchial 
epithelial cells after transfection with an adenovirus 12-SV40 hybrid virus (Xatzipsalti and 
Papadopoulos 2007). A change in codon 47 of one allele to p53 was found in this line. But 
this change was also present in another sample, and later it was established that this change is 
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present in 3% of individuals in the population, and it is most likely a polymorphism (Reddel 
et al. 1995; Hussain et al. 2001).  
 
The experimental system Hepa1c1c7 cells 
A cancer cell line (Hepa1c1c7), derived from liver from mice. Several studies have shown 
that B[a]P and other PAHs can induce apoptosis in Hepa1c1c7 cells. The metabolism of these 
cells represent the situation in vivo better than many ofther cells closer to exposure sites, like 
cells from the lung. This cell line expresses aromatic hydrocarbon (Ah) receptor and is shown 
that it can induce cytochrome P450A1, which is an important enzyme in metabolism of 
PAHs. Several mutants of this cell line exist, among others an AhR-defective mutant.  
 
Determination of cell death by fluorescence.  
The sensitivity (the lower detection limit) of fluorescence microscopy is good since the 
signal-to-noise ratio is so high. By using fluorochromes no enzymes are needed that can be 
influenced by temperature, pH or other limiting conditions. The output of data is also large, as 
many cells can be stained at the same time, increasing the throughput of an experiment. This 
procedure is fairly easy and has a low cost, compared to other techniques like ELISA. By 
adding more than one flourochrome at the same time, more than one parameter can be 
investigated.  
 
Cytokine release 
Enzyme-Linked ImmuoSorbent Assay (ELISA) is an immulologic method that gives exact and 
sensitive detection, meanwhile it quantified the level of antigens in the supernatant. 
Sandwich-ELISA, were an antibody is attached to the bottom of a well gives both antigen 
binding and immunospesificity, while a secondary antibody that is conjugated to an enzyme 
gives detection and is an amplification factor. This can only be the case if the antigen has two 
epitopes and lead to double sensitivity, while Western blotting and flow cytometry only have 
simple sensitivity. In this study, the CXCL8 cytokine was investigated (Leng et al. 2008). 
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Flow cytometry 
Flow cytometry is a very objective method, since it is automated and do not require visual 
inspection of slides. The physical properties of cells are measured by flow cytometry and also 
the fluorescence characteristics. Size and internal complexity of cells are detected by light 
scatter signals. By using fluorochromes that attach to proteins or DNA the emitted signal from 
a laser exciting the flouorochromes to a higher state can be gathered with optics and by 
running it through filters and dichronic mirrors the wavelength of interest can be isolated. The 
number of cells that are scored in this technique are ≥ 5000 cells, that will strengthen the 
statistically powers (Avlasevich et al. 2011; Wedemeyer and Potter 2001). Analysis of DNA 
content can display information of cell ploidy, position in the cell cycle and the frequency of 
apoptotic cells. Distribution of cells in the major phases of the cell cycle is based on 
differences in DNA content between cells in prereplicative phase (G0/1) versus the cells that 
replicate DNA ( S phase) versus the postreplicative plus mitotic (G2 + M) phase cells. This 
method rely on staining of DNA by a fluorochrome (Darzynkiewicz, Halicka, and Zhao 
2010). 
 
Cell cycle 
The cell cycle consist of phases were various events occur. They are called G0, G1, S, G2 and 
M phase. Cells in G0 are said to be quiescent, they are not dividing. G1 is the phase before a 
cell start to divide, the cell will increase in size. DNA is replicated in the following S phase. 
G2 ensures that the cell is ready to enter the M phase and divide. M phase, mitosis, is where 
the cell divides into two daughter cells (Clarke and Allan 2009).  
 
Western blotting 
In short, Western blotting is the transfer of proteins that are separated by electrophoresis to a 
nitrocellulose membrane. The first consideration that needs to be made is the creation of 
protein lysate. The Western blot analysis will only be as good as the protein lysates prepared 
for polyacrylamide gel electrophoresis (PAGE). The proteins in the sample should be 
collected and lysed quickly, preferably while chilled. SDS-PAGE is the most common 
strategy to electrophoretically separate proteins, and it also the method used in this study. 
SDS is a strongly anionic detergent, that binds denatured proteins within their hydrophobic 
regions, as a result becomes negatively charged. The amount of SDS that binds to the 
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denaturized proteins is approximately proportional to the molecular mass of the polypeptides 
facilitating directional migration based on the polypeptide size. After electrophoresis is done, 
a replica of the separated proteins can be made on a membrane, in this study a nitrocellulose 
membrane was used, this is called electro blotting. After blots are prepared they need to be 
blocked. This is because it can help mask non-specific binding sites on the membrane itself 
and it can promote renaturation of antigenic sites. After blocking the membrane is probed 
with a primary antibody that was created for the antigen at target. The membrane is then 
washed and incubated with an enzyme-conjugated secondary antibody that is reactive to the 
primary antibody. The membrane is washed again incubated with an appropriate enzyme 
substrate. The signal is then detected either with film or imaging for chemiluminescence 
(MacPhee 2010; Alegria-Schaffer, Lodge, and Vattem 2009).  
 
DNA damage 
The comet assay (single cell electrophoresis) is a popular method to measure low levels of 
damage in cellular DNA. Cells are embedded in agarose on a film and lysed. Supercoiling 
will be released by strand breaks, and loops can expand. These will move when exposed to 
electrophoresis and move against the anode, giving the appearance of a comet tail. The comet 
assay measures DNA strand breaks (SSBs) and alkali-labile sites (ALS). With a modification 
it can also measure oxidized bases such as 7.8-dihydro-8-oxoguanine (8-oxoG) and various 
ring-opened purines, this is enabled by including formamidopyrimidine DNA N-
glycosylase/AP-lyase (Fpg). The % of DNA in the tail reflects the break frequency. (Hansen 
et al. 2010; Shaposhnikov, Frengen, and Collins 2009). Fpg is a multifunctional protein (from 
Escherichia coli) that excises damaged purine bases from DNA to generate aldehydic abasic 
sites and then catalyzes the successive cleavage of the phosphodieste bonds first at the 3’-side 
and then on the 5’-side of the abasic site to generate 5’- and 3’-phosphate ends, thereby 
exciting the deoxyribose residue (Bhagwat and Gerlt 1996). To allow comparison between 
different replicates of an experiment it is important that the films get the same treatment, but 
also for the same length of time. As prolonged electrophoresis for instance would give longer 
tails and hence influence the results, as they would appear as more damage on DNA.  
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Statistic analysis 
ANOVA, analysis of variance, can compare two or more means at the same time. To use 
ANOVA the data have to be independent of each other, and normally distributed and have 
similar varians for each sample.  
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4. CONCLUSION 
 
DNA is at all times subject to damage, mutations and other types of harm. Both caused by the 
cell itself and from external sources like PAHs. This is the reason why cells have developed 
an intricate resonse system to detect and repair damage, or if the damage is too great to 
manage, trigger apoptosis. In this study we have showed that different PAHs induce cell death 
in both BEAS-2B and Hepa1c1c7 cells, however the effect was greatest in the hepatoma cell 
line. We therefore investigated the signals given after exposure to PAHs in the Hepa1c1c7 
cell line.  
 
 BEAS-2B cells exposed to 1-NP showed increased cell death, in contrast to 1.3-DNP 
and 1.8-DNP. There was also an increase in CXCL8 from the cells after exposure to 1-
NP. 
 
 Hepa1c1c7 cells exposed to the nitro-PAHs showed both apoptotic and necrotic cell 
death. 1.3-DNP proved to be the most cytotoxic compound of the three nitro-PAHs 
tested. An increase in cell death could be seen between 12 and 20 hrs. 1.8-DNP gave 
no marked cell death until at a later time. The increased cell death found in Hepa1c1c7 
cells when compared to BEAS-2B cells were likely due to a higher degree of 
metabolic activation  often found in Hepa1c1c7 cells. 
 
 1.3-DNP induced cleavage of both caspase 3 and PARP indicating an apoptotic 
response. 1.8-DNP, however, gave no response to these two apoptotic markers. 
Indicating that there is no signals telling the cell to undergo apoptosis and die, which 
can lead to the compound being more genotoxic and mutagenic. The toxicity of 1.3-
DNP was partly inhibited by zVAD-FMK indicating that caspases take part in the 
activation of the apoptotic process, but also suggesting that there could be an 
alternative pathway bypassing the caspase activation.  
 
 All the compounds lead to alterations in cell cycle. 1.8-DNP lead to an accumulation 
of cells in S-phase, in contrast 1–NP and 1.3-DNP gave an accumulation of cells in 
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G2.phase . 1.8-DNP gave also a marked increase in p53 phosohorylation together with 
oxidized damage.  
 
 1-NP, 1.3-DNP and 1.8-DNP showed a remarkable increase in oxidized damage. 
Suggesting that there can be ROS formation during metabolism of the compounds 
contributing to DNA damage.  
 
 In addition to phosphorylation of p53 by 1.8-DNP we saw an activation of H2AX and 
Chk1 which supports a DNA damage response even if the cells do not die. We find 
p53 to be translocated to nuclei, however, observed no marked increase of NOXA nor 
p21 (data not shown). Thus, as previously suggested, the DNA damage response are 
possibly not fully triggered/inhibited; alternatively, there could be another damage 
signalling pathway in the cell that is needed to be triggered for execution of apoptosis.  
 
 PFT-α fully inhibited 1.3-DNP induced cell death indicating that the p53 nuclear 
translocation and the following transcription is playing a central role in the apoptosis 
pathway. In contrast, PFT-µ did not inhibit apoptosis, thus suggesting that in this case 
a p-p53 translocation to the nucleus is not needed for the apoptotic process 
 
 1.3-DNP seemed to demand a smaller p53 response in order to trigger apoptosis. 
Immunocytochemical studies revealed that the p53 did accumulate somewhat in the 
nucleus in apoptotic cells. In addition, we saw some DNA damage response. 1.8-DNP 
did induce activation of Chk1 and p53. In contrast to the previous study, p53 was 
found to translocate to the nucleus, however, no effect was seen on NOXA. These 
findings suggest that other parallel cell death pathways may be lacking. 
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FURTHER WORK 
 Comparative analysis of cytokines in Hepa1c1c7 cells by investigating levels of MIP-
2 to compare these to the CXCL8 in BEAS-2B. 
 
 The partly inhibition of cell death after 1.3-DNP exposure  zVAD-FMK it can be 
caused by use to low concentration, studies with higher concentration could rule out if 
there really is a  secondary pathway if a higher concentration led to fully inhibition of 
cell death.  
 
 A further clarification and characterization of the DNA damage response, as well as 
any role of other cellular death signaling pathways are highly needed..  
 
 Inhibition of aldo-ketoreductase 1C2 by UA (ursodeoxycholic acid). Aldo-
ketoreductase 1C2 has been essential for 1-NP induction of p53, so a further 
investigation if the same would regard 1.3-DNP would be of great interest.  
 
 Investigation of apoptosis by flow cytometri would be interesting, as that is a totally 
different methology and would support our finding.  
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ABSTRACT 
 
We show that nitrated-polycyclic aromatic hydrocarbons (nitro-PAHs) induce cell death in 
Hepa1c1c7 cells, as measured by fluorescence microscopy. BEAS-2B cells, however did not 
show any relevant effects. 1.3-DNP induce formation of the active form of both caspase 3 and 
its intracellular substrate, poly(ADP-ribose)polymerase (PARP). The most important finding 
was that the most mutagenic and carcinogenic compound, 1.8-DNP, induced a delayed cell 
death, when compared to 1.3-DNP, despite that this compound seemed to give the same 
amount of oxidative damage, judged by comet assay, increased phosohorylation of p53 and 
accumulation of cells in S-phase. 1-NP and 1.3-DNP gave an accumulation of cells in G2-
phase. 1.3-DNP seemed to demand a smaller p53 response in order to trigger apoptosis. 
Immunocytochemical studies revealed that the p53 did accumulate in the nucleus. In addition, 
we saw some DNA damage response. 1.8-DNP did induce activation of p53 and Chk1, 
however, no effect was seen on NOXA. These findings suggest that other parallel cell death 
pathways may be lacking.  
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INTRODUCTION 
 
Polycyclic aromatic hydrocarbons (PAHs) are environmental pollutants formed during 
incomplete combustion of organic material. An important subgroup of PAHs is the nitro-
PAHs. They are formed when organic material is burned. PAHs are found on diesel exhaust 
particles. Epidemiological studies have shown that exposure to diesel exhaust and urban air 
pollution is associated with an increased risk of lung cancer (Garshick et al. 2004; Arlt 2005). 
Nitro-PAHs have shown in studies, that they are highly mutagenic in bacterial systems and 
that they can cause tumours in animal models (Takayama et al. 1983). Nitroarenes are 
common environmental pollutants (Purohit and Basu 2000).  
 
Metabolism of nitro-PAHs is usually done by nitroreductases, CYP enzymes and phase II 
biotransformation enzymes (Purohit and Basu 2000). Cytochrome P450 (CYP) enzymes can 
activate PAHs to epoxide intermediates that can be further converted to more reactive dipole-
epoxides. Nitro-PAH can also be converted to N-hydroxylated metabolites that subsequently 
are modified by phase II enzymes, such as acetyltransferase and sulfotransferase, to ultimate 
carcinogens (Shimada and Fujii-Kuriyama 2004). However, the most important metabolism 
of nitro-PAHs is the reductive pathways for nitroreduction that can lead to the corresponding 
amine with the production of electrophilic reactive intermediates or reactive oxygen species, 
depending on the nitroreductase (NR) and the availability of oxygen. One NR is oxygen 
insensitive, and have a two electron reduction and the other is oxygen sensitive and catalyses 
a one-electron reduction, which generates the corresponding nitro anion radical that can be 
oxidized back to the parent nitro compound in the presence  of molecular oxygen (Ask et al. 
2004). Due to the redox-cycle that takes place during the regeneration of the nitro compound 
and production of superoxide anion, there is a dismutation that yields hydrogen peroxide. This 
is the reason why metabolism of some nitroaromatic compounds can lead to reactive 
intermediates and potentially reactive oxygen species (Ask et al. 2003).   
 
Nitro-PAH can induce different types of DNA damage. Formation of DNA adducts has been 
investigated in a numbers of articles (Ma and Ma 2002; Landvik et al. 2007). Oxidative 
damage can also be caused by nitro-PAHs, this can be due to metabolism that forms reactive 
metabolites. Metabolism by nitroreductases can also cause an ATP depletion in the cell.  
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DNA damage resulting from different sources produces a complex protein kinase signalling 
cascade that promotes repair of the damaged DNA and activates cell cycle checkpoints or 
apoptosis (E et al. 2011).  DNA damage response is the detection system for lesions formed 
on DNA, DNA adducts as well as single- (SSB) and double- strand breaks (DSB). ATM 
ataxia telangiectasia mutated) is the major response to DSBs. This kinase is 
autophosphorylated when breaks occur, and will activate a number of downstream signals by 
phosphorylation resulting in a halt of cell cycle (Chk2) and initiating DNA repair (Ghosh et 
al. 2011).  ATR (ATM  and Rad3-related) is activated by DNA replication intermediates and 
thus monitor the DNA replication fork (Hurley and Bunz 2007; Kang et al. 2011). It does 
activate Chk1 by phosphorylation. Chk1 and Chk2 are checkpoint kinases and induce arrest at 
specific stages of the cell cycle, hence delaying cell division to let repair of DNA to take 
place. More specifically, they interact with the p53 protein, known as “the guardian of the 
genome”. p53 is a tumour suppressor  which controls genome stability by inducing growth 
arrest or apoptosis. It responds to DNA damage in various ways, depending on cell and stress 
types including DNA damage including that caused by gentotoxic pollutants such as PAHs, 
hypoxia and ultraviolet radiation irradiation. In response to DNA damage it is phosphorylated 
via Chk1/2, which leads to activation of the protein and dissociation from its repressor Mdm2. 
p53 directly up-regulates the expression of p21 resulting in cell cycle arrest, as well as cell 
surface receptors like Fas, mitochondrial pro-apoptotic proteins like Bax, Bak, PUMA and 
NOXA (Strom et al. 2006; Zhang, Liu, and Wang 2011). If the damage is too severe induction 
of the latter proteins will induce cell death often via apoptosis (Smits, Reaper, and Jackson 
2006; Smith et al. 2010; Clarke and Allan 2009). H2AX is a member of these proteins, 
detecting the often lethal double strand breaks (DSB), and is than phosphorylated into γH2AX 
and function as a tumour suppressor protein. (Seviour and Lin 2010; Coster and Goldberg 
2010).   
 
Cell death is traditionally classified as apoptosis or necrosis. Apoptosis is an active process 
that requires energy to be executed. The programmed cell death, as it often is referred to, 
involvement of caspases and is characterized by shrinkage of the cell, nuclear fragmentation 
and chromatin condensation followed by the formation of apoptotic bodies. Necrosis, 
however, is characterized by cellular swelling and rupture of the plasma membrane, and it is 
often looked at as a passive type of cell death. Of other types of cell death does include 
senescence, autophagy and mitotic catastrophe (Malhi, Guicciardi, and Gores 2010),. 
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In previous studies Hepa1c1c7, liver epithelia cells, have been used as a model system to look 
at PAHs as they are competent to metabolic activate these chemicals into reactive metabolites. 
They have proven to be an interesting model to study PAH/nitro-PAHs-induced cell death 
(Solhaug et al. 2004; Solhaug, Refsnes, and Holme 2004; Solhaug et al. 2005; Landvik et al. 
2007). The most important finding is that pro- and anti-apoptotic signals often occur 
simultaneously. In this context, it is important to further elucidate cellular signaling pathways 
modulating the survival/ death balance, which is of crucial importance for final  carcinogenic. 
In a more recent study by Landvik 1.8-DNP induced little cell death despite the fact that it 
gave the most DNA damage, judged by DNA adducts, p53 activation and S-phase 
accumulation of cells, suggesting that the mutagenic and carcinogenic potential might be 
increased as the cells survive. 
 
In the present study we have extended these findings by measuring single stand brakes and  
oxidative DNA damage by comet assay, and as well as the DNA-damage response has been 
investigated.  
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MATERIALS AND METHODS 
 
Chemicals 
 
LHC-9 cell culture medium was provided by Invitrogen (Carlsbad, CA, USA). Alexa Fluor 
388 was purchased from Invitrogen (Eugene, Oregon, USA). Sterile HBS and purified 
collagen, PureCol™ was from Inamed Biomateriamls (Freemont, CA 94538 USA). 1-
nitropyrene (1-NP), 1,3-dinitropyrene (1,3-DNP), 1,8-dinitropyrene (1,8-DNP), 
Benzo[a]pyrene (B[a]P), bovine serum albumin (BSA), dimethyl sulfoxide (DMSO), 
ethylenediamineteraacetic acid (EDTA), Hoechst 33258, Hoechst 33342, aprotinin, Pifithrin-
µ (PFT-µ), Ponceau S, phenylmethylsulfonyl fluoride (PMSF), propidium iodide (PI),   
polyoxyethylene octyl phenyl ether (Triton X-100) and zVAD-FMK were obtained from 
Sigma-Aldrich Chemical Company (St. Louis, MO, USA). Pifithrin-α (PFT- α) and Pepstatin 
A were from Calbiochem (Cambridge, MA, CA, USA). Leupeptin was from Amersham 
Biosciences (Uppsala, Sweden). Bio-Rad DC protein assay from Bio-Rad Laboratories, Inc 
(Hercules, CA, USA). Foetal calf serum (FCS), gentamycin, MEM alpha medium with L-
glutamine, without ribonucleosides and deoxyribonucleosides were from Gibco BRL (Paisley, 
Scotland, UK). UltraPure™ Low Melting-Point Agarose was purchased from Invitrogen 
(Paisley, UK). Cytokine ELISA assay for CXCL8 (Human IL-8 Cytoset) was purchased from 
Biosource International (Camarillo, CA, USA). FPG enzymes were kindly donated by Prof. 
Andrew Collins (Department of Nutrition, Universtiy of Oslo, Norway). All other chemicals 
were of analytical grade and purchased from commercial sources.  
 
Antibodies 
 
Antibodies against: cleaved caspase 3, phospho-p53 (Ser15), p53, phospho-Chk1 (Ser345), 
cleaved PARP (Asp214), β-actin, phospho-H2A.X (Ser139) were obtained from Cell 
Signaling (Beverly, MA, USA); NOXA were purchased from Santa Cruz Biotechnology, Inc, 
(Santa Cruz, CA, USA), As secondary antibodies horseradish peroxidase-conjugated goat-
anti-rabbit (Sigma Chemical Company, St. Louis, MO, USA), horseradish peroxidase-
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conjugated rabbit anti-goat or rabbit anti-mouse IgG from Dako (Glostrup, Denmark) were 
used.  
 
Cell culture 
 
The mouse hepatoma Hepa1c1c7 cell line was purchased from European Collection of Cell 
Culture (ECACC). Earlier studies have shown that this cell line is a good substitution to 
bronchial epithelial cells as the metabolism resembles the in vivo situation (Landvik et al. 
2007). Maintenance of the cells was done according to ECACC’s guidelines and they were 
grown in alpha MEM medium with 2mM L-glutamine, without ribonucleotides and 
deoxyribonucleotides. Supplemented to the media were 10% heat-inactivated foetal calf 
serum (FCS, 10%) and 0,1mg/mL of the fungicide gentamycin. The cells were incubated in 
5% CO2 humified air at 37
o
C, where they were kept in a logarithmic growth 1-9x10
9
 cells/75 
cm
2 
flasks and split twice a week, Monday and Friday respectively. When splitting the cells, 
they were washed with phosphate-buffered saline (without Ca
+
 and Mg
2+
; PBS) and added 
0.0025% trypsin, which was removed shortly afterwards. The cells were then incubated for 1 
min at 37
o
C. The trypsin was inactivated by adding culture medium with FCS, and 1/10-1/20 
of the cells was transferred into new flasks for further growth. On Wednesday fresh medium 
was added. 
 
BEAS-2B cells, an immortalized SV40-adenovirus-hybrid (Ad12SV40) transformed human 
bronchial epithelial cell line were purchased from the American Tissue Type Culture 
Collection (ATTCC, Rockville, MD, USA). The p53 of this cell line is mutated in codon 47 
but this does not change its functional properties (Hussain et al. 2001; Reddel et al. 1988). 
Cells were grown in LHC-9 medium on collagen (PureCol™)-coated culture flasks and 
dishes. Cells were incubated in 5% CO2 humidified air at 37
o
C, were they where kept in a 
logarithmic growth (1-9x10
6
 cells/75 cm
2
 flasks), and split twice a week, Monday and 
Thursday respectively. When splitting the cells, they were washed with phosphate-buffered 
saline (without Ca
+
 and Mg
2+
; PBS) and added 0.0025% trypsin, which was removed shortly 
afterwards. The cells were then incubated for 3 min at 37
o
C. The trypsin was inactivated by 
adding LHC-9 medium with fatty acid-free albumin, and 1.2x10
6
 or 1.0x10
6
 (Mondays and 
Thursday respectively) of the cells were transferred into new coated flasks for further growth. 
The day after the splitting procedure, fresh medium was added.  
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Exposure 
 
Hepa1c1c7 cells were seeded in dishes (35mm 6-well culture dishes or 90mm culture dishes) 
or trays at a concentration of 70 000 per cm
2
 the day before exposure. Fresh medium was 
added before exposure. When inhibitors were used, the cells were pre-incubated with the 
inhibitor for one h before adding test substances. Cells were treated with 1-NP, 1.3-DNP, 1.8-
DNP or DMSO only as a control. All the compounds were dissolved in DMSO. The amount 
of DMSO added to the culture medium was ≤ 0,5%. After exposure cells were analyzed by 
light microscopy, fluorescence microscopy, flow cytomerty, comet assay, and western 
blotting.  
 
BEAS-2B cells were plated in 35mm 6-well dishes (8x10
4
 or 10x10
4
 cells/well). Fresh 
medium was added the day after seeding and right before exposure. Cells were treated with 1-
NP, 1.3-DNP or 1.8-DNP, all the compounds were dissolved in DMSO or DMSO only as a 
control. The amount of DMSO in culture medium was ≤ 0,5%. After exposure cells were 
analyzed by light microscopy, fluorescence microscopy or ELISA. 
 
Light microscopy 
 
After exposure to the polycyclic aromatic hydrocarbons (PAHs) for 24hrs, 48hrs and 72hrs, 
the culture morphology was determined using light microscopy. To judge the relative amount 
of cytotoxicity in the cultures, the floating (dead) cells were compared to the attached (mostly 
living) cells. To record the living cultures, a digital camera (Nikon D40) coupled to the 
microscopy was used.  
 
Fluorescence microscopy 
 
To further characterize cytotoxicity, the cells were analyzed using fluorescence microscopy 
after staining to view changes in nuclear morphology and plasma membrane damage 
associated with apoptosis and necrosis. The cells were exposed to various concentrations (1-
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30 µM) of different PAHs for 24 and 72 hrs. After trypsinating and staining of the cells with 
Hoechst 33342 (5 μg/mL) and propidium iodide (PI) (10 μg/mL), the cells were incubated in 
the dark for 30 min at room temperature. Followed by centrifugation, the pellet was 
resuspended with foetal calf serum (FCS) and prepared on a microscopy slide and air dried 
quickly. Both dye stains DNA, but only PI cannot penetrate an intact cell membrane. Cell 
morphology was evaluated using a Nikon Eclipse E 400 fluorescent microscope, with an UV-
2A excitation filter 330-380 nm (magnification x 1000). At least 300 cells were counted per 
slide and classified as either viable, apoptotic or necrotic. Cells with clearly condensed and/or 
fragmented nuclei (both PI-negative and PI-positive) as well as PI-negative cells with partial 
chromatin condensation were counted as apoptotic and determined as a fraction of the total 
number of cells. PI-stained cells exhibiting a rounded morphology and homogenously stained 
nucleus (typical necrotic) or partially condensed chromatin with less flourescent intensities 
were termed PI positive. Non apoptotic cells, excluding PI, were considered as viable cells. 
(Asare et al. 2009; Solhaug, Refsnes, and Holme 2004) 
 
Cytokine measurements 
 
Enzyme-Linked Immuno-Sorbant Assay (ELISA), the biochemical technique for cytokine 
measurements that is the most widely used and best validated. This method enables high 
sensitivity and specificity to measure cytokines in a sample.(Leng et al. 2008) 
 
BEAS-2B cells were grown in 35 mm, six-well dishes, exposed to selected compounds and 
incubated for 24 hrs at 37
o
C. After exposure the medium was harvested and centrifuged at 
250xg to remove floating cells. The final supernatants were stored at -70
o
C. Cytokine protein 
levels were detected by enzyme-linked immunosorbent assay (ELISA) according to the 
manufacturer’s guidelines. Absorbance was measured and quantified using a plate reader 
(TECAN Sunrise Phoenix Research Products, Hayward, CA, USA) complete with software 
(Magellan V 1.10).  
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Flow cytomerty and cell cycle analysis 
 
In flow cytometry, a suspension of cells is passed through a highly focused beam of laser 
light. Flow cytometry measures both the deviation of light (light scattering) as a function of 
size and optical properties of the cells as well as the absorption/emission of fluorescence from 
cell components that were stained with a fluorescent dye. This enables multiple parameters 
from each cell to be recorded at the same time; e.g. granulation and size. (Otsuki, Li, and 
Shibata 2003) 
 
After treatment, cells were trypsinated and prepared for flow cytometry. The DNA of the cells 
were stained by incubating approximately 0.5x10
6
 cells with Hoechst 33258 (1.0 μg/mL) and 
Triton X-100 (0.1%) in the dark for 15 min. Triton X-100 makes the cells permeable and 
Hoechst 33258 stains DNA. To measure the blue fluorescence an Argus 100 Flow cytometer 
(Skatron, Lier, Norway) were used. Percentages of cells in the different phases of cell cycle 
were distinguished on the basis of their DNA content (Hoechst fluorescence) and cell size 
(forward light scatter). Percentages of cells in the different phases of cell cycle were estimated 
using the Multicycle  Program (Phoenix Flow system, San Diego, CA, USA) (Darzynkiewicz 
and Huang 2004). 
 
Western blotting immunoassay 
 
Western blotting is a method to separate and to identify proteins. This is done by SDS-PAGE 
(sodium dodecyl sulphate polyachrylamide gel electrophoresis) which denaturates an equal 
amount of protein and separate them according to size. These are then transferred to a 
nitrocellulose (used in our study) support membrane by electrophoresis. Primary monoclonal 
or polyclonal antibodies are added to interact with a specific antigen epitope, which is 
presented by the target protein attached to the support membrane. Additionally a secondary 
antibody, conjugated with HRO (horse radish peroxidase) is added and binds to the primary 
antibody-antigen complex. Luminescent substrates are then used to visualize the bound 
components.  
 
Hepa1c1c7 cells were grown in 90 mm Culture dishes (7x10
5
 cells/dish) and exposed to 
various test substances for 24 hrs as described earlier. Cells were frozen at -20
o
C for one h 
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and then at -80oC for at least 24 hrs, thawed and lysed in 20 mM Tris buffer, pH 7.5, 150 mM 
NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM 
b-glycerol phosphate, 1mM Na3VO4, 1 mM NaF, 10 mg/mL leupeptin, 1 mM PMSF, 10 
mg/mL aprotinin and 10 mg/mL pepstatin A. After cell lysis, solution were sonicated, 
centrifuged (290xg), and supernatant containing cellular proteins were collected. Protein 
concentration was measured by using a Bio-Rad DC protein assay kit. The samples were 
adjusted to contain equal amount of protein by adjusting with lysis buffer. 5 x SDS-PAGE 
sample buffer (0.312 M Tris-HCl, pH 6.8, 10% DSD, 25% β-mercaptoethanol, 0.005% 
bromophenol blue) and 10% glycerol was added. Samples were mixed and boiled for 5 min.  
 
A sample of 12.5 μg protein in each well was subjected to 12% or 15% SDS-PAGE. Proteins 
were transferred to nitrocellulose membrane by electro blotting. Staining with Ponceau S 
revealed equal protein loading. The blots were blocked with 3% fat-free dry milk, and then 
incubated with primary antibodies overnight at 4
o
C or 2 hrs at room temperature in 3% fat-
free dry milk or 5% bovine serum albumin (BSA), according to the manufacturer’s 
recommendations. Then blots were incubated with horseradish peroxidase-conjugated 
secondary anti-rabbit, anti-mouse or anti-goat antibodies 1:5000 for 2 hrs at room 
temperature. Between each step the membranes were washed three times in cold 1xTBS (Tris-
buffered saline). The western blots where developed using either the ECL chemiluminescence 
system according to the manufacturer’s instructions or digitally. The results are from one out 
of three individual experiments.  
 
Immunocytochemistery 
 
Immunocytochemistery is a technique, like Western blotting, detecting proteins by specific 
antibody binding. The major difference to Western blotting is that the antibody-antigen 
interaction is within the cells, which enables visualization of the protein in question relative 
too for example the nucleus of the cell.  
 
Hepa1c1c7 were exposed to 30 µM of 1.3-DNP and 1.8-DNP or DMSO only as a control, for 
24 hrs as described earlier and seeded in 60 mm dishes (7x10
5
 cells/well). Cells were washed 
in phosphate-buffered saline (PBS), and adherent cells were fixed with absolute methanol for 
5 min in room temperature. To divide each dish in 3 different areas to be treated individually, 
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a PAP Pen was used. It is a special marking pen that provides a thin, film-like, green-tinged, 
hydrophobic barrier when a circle is drawn around a specimen on a slide, and prevents mixing 
of reagents when differently staining two or more sections on the same slide. Cells were 
incubated in humidified atmosphere, at room temperature overnight in the dark with primary 
antibody diluted in PBS with 1% BSA. One area of the dish was the control area without any 
primary antibody, serving the purpose to see if there were any unspecific binding that would 
cause auto fluorescence later.  Finally the cells were incubated with secondary anybody Alexa 
Flour 488 (1:50) for 2 hrs under the same conditions as the primary antibodies. Between each 
step the dishes were washed three times with PBS. The last step in the procedure included 
adding a drop of DAPI GOLD, which stains the nuclei, as a mounting medium, and sealing 
with a cover glass to prevent drying and movement under the microscope. Data is from one  
individual experiment.  
 
 
Single cell gel electrophoresis (comet assay) 
 
The comet assay (single cell gel electrophoresis or SCGE) is a quick, simple, sensitive, 
reliable and fairly inexpensive way of measuring DNA damage. The alkaline comet assay 
resolves break frequencies up to a few thousand per cell, so the distances between breaks are 
of the order of 10
9
 Da. The DNA is digested with a lesion-specific repair endonuclease, 
formamidopyrimidine-DNA N-glycosylase (Fpg, active on 8-OH-gua), which introduces 
breaks at sites of damage. (Collins, Dobson, et al. 1997) 
 
The comet assay was performed as described previously (Hansen et al. 2010). In short, cells 
were exposed to 1-NP, 1.3-DNP, 1.8-DNP (1, 3, 10 or 30 µM) or B[a]P (10 µM) for 24 hrs. 
Media were removed and cells were trypsinated and resuspended at 10
6
 cells/ mL in medium 
containing 10% FCS. Cells were dissolved in 0.75% low melting point agarose dissolved in 
PBS with EDTA and molded as 48 (7 µL) gels onto GelBond films attached to plastic frames 
to facilitate subsequent treatment steps. After lysis over night at 4
o
C (2.5 M sodium chloride, 
0.1 M Na2EDTA, 10 mM Trizma base, 1% lauroylsarcocine sodium salt (≥94%) pH 10, with 
1% Triton X-100 and 10% DMSO freshly added), films were washed in destilled water and 
then treated with a bacterial formamidopyrimidine-DNA glycosylase (FPG) enzymatic extract 
(1.0 µg/mL) or in the same buffer but without the FPG enzyme extract (1 h, 37
o
C), and DNA 
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strand breaks and alkali-labile sites were detected. DNA unwinding was performed in 
electrophoresis buffer in the dark (5 + 35 min, 4
o
C). After electrophoresis at 8-10
o
C (0.8 
V/cm, 300 mA, 20 min, pH 13.2) and neutralization (0.4 M Trizma base buffer pH 7.5 for 2 x 
5 min), films were fixed in ethanol and dried. Rehydrated films were stained with SyrbGold 
(0.08 µl/ml in TE buffer, pH 7.4, 20 min in the dark) and scored with a Comet IV capture 
system (version 4.11; Perceptive Instruments, UK) counting 30 nuclei per gel window. The 
level of DNA damage is expressed as tail intensity, i.e. per cent fluorescence in the comet tail, 
relative to the total fluorescence of the comet.  
 
Statistical analysis 
 
All data were representatives of three or more independent experiments with identical 
conditions. Data is presented as mean ± SEM. Statistical significance was evaluated using 
analysis of variance (ANOVA) with the Dunnet post-test (two way ANOVA). This enables 
the possibility to obtain p-values to determine statistically significant differences between 
controls and treated sets. P<0.05 was considered significant. All calculations were executed 
with GraphPad Prism software (GraphPad Software Inc., San Diego, CA, USA).  
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RESULTS 
 
Cell death 
 
Morphology changes  
 
BEAS-2B cells and Hepa1c1c7 cells were treated with different nitro-PAHs for 24 and 72 hrs, 
or DMSO only as a negative control. The morphology of the cultures was examined by using 
a reverted light microscopy. To judge the relative amount of cytotoxicity in the cultures, the 
floating (dead) cells were compared to the attached (mostly living) cells. As can be seen in 
figure 2, BEAS-2B did show little cytotoxicity, only 1-NP gave a marked effect. Seen in 
figure 3, Hepa1c1c7 showed increased cytotoxicity with treatment to 1-NP and 1.3-DNP, but 
gave no marked effect with treatment to 1.8-DNP. In addition, treatment to 1-NP resulted in 
formation of vacuoles.  
 
Induction of apoptosis and necrosis 
 
BEAS-2B and Hepa1c1c7 cells were treated with the different nitro-PAHs and DMSO for 24 
hrs, then to further characterize the effects cells were stained with Hoechst 33342 and PI. This 
staining enables differentiation between apoptotic, necrotic and viable cells. Pictures in figure 
4 shows cell death; typical living, apoptotic, necrotic, as well as apoptotic-necrotic cells 
induced by the compound that were tested. Some PI-positive cells showed partial chromatin 
condensation, indicating apoptosis, but with damage to the plasma membrane (apoptotic-
necrotic cells). These cells were categorized and counted as apoptotic.  
 
After exposure, 1-NP increased cell death in BEAS-2B cells. Increasing from 6% in control to 
245% in 30 µM  (Fig. 5A). No effect was seen on 1.3-DNP and 1.8-DNP as seen in figure 5.   
 
Hepa1c1c7 cells however, did show increased cell death following 24 hrs of treatment with 
1.3-DNP after 24 hrs of exposure (Fig. 6); increasing from 4 % in control to 31 % and 50 % at 
10 and 30 µM, respectively. In contrast 1.8-DNP did not induce any significant cell death 
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after 24 hrs. However, after 72 hrs a significant effect was seen at 30 µM, with cell death 
increasing from 6.2 % in control to 25 % in the highest concentration, in details by (Fig. 7B). 
The time course of cell death induced by 1.3-DNP was further investigated by harvesting cells 
after 0, 8, 12, 20 and 24 hrs. A significant increase in apoptosis and necrosis were first seen 
after 12 hrs, from 1% to 3% in control and 30 µM, respectively. After 20 hrs the combined 
cell death was increased to 37%, and after 24 hrs it was at 36%.  
 
Cytokine release 
 
CXCL8 
 
To measure the cytokine response from the cells, the ELISA technique was used. CXCL8 
may contribute to tumor growth. This study showed a small increase of IL-8 after 1-NP 
exposure, in contrast 1.3-DNP and 1.8-DNP showed no increase (Fig 8).  
 
 
Cleavage of Caspase 3 and PARP 
 
Caspases are normally activated when apoptosis is executed, and can of that reason be used as 
a marker for apoptosis. Caspase 3 is a effector caspase, that can cleave several structural and 
regulatory proteins in apoptotic processes (Bratton and Cohen 2001). Cleavage of poly (ADP-
ribose) polymerase (PARP) by caspase-3 is known to be a hallmark of apoptosis (Diefenbach 
and Burkle 2005). After exposure for 24 hrs to various concentrations of  1.3-DNP, 
Hepa1c1c7 were sampled and the lysate was analyzed with the western blotting method, The 
analysis showed an reduction in the level of protein with a similar molecule weight 
corresponding pro-caspase 3, and an increase  in level of the cleaved caspase 3 at 10 and 30 
µM (Fig. 9A). Western analysis also showed induced cleavage of PARP with 1.3-DNP (Fig 
9B). In contrast, 1.8-DNP did change neither caspase 3 nor PARP. See figure 9A and B.  
 
Inhibition of cell death; zVAD-FMK 
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zVAD-FMK is a cell-permeable caspase inhibitor that irreversibly binds to the catalytic site of 
caspase-1 and caspase-3 related proteases, and can inhibit induction of apoptosis (Chen et al. 
2011). Light microscopy and fluorescence microscopy analysis after Hoechst 33342 and PI 
staining showed partly inhibition of 1.3-DNP induced cell death (Fig. 9C ) . Cell death was 
reduced from 31 % in the positive control to 19 % in samples incubated with Z-VAD-FMK 
 
Cell cycle alterations 
 
To detect any alterations of cell cycle by nitro-PAHs Hepa1c1c7 cells were analyzed by flow 
cytomety, to determine the relative amount of cells in G1, S and G/M phase after 24 hrs of 
exposure. All three compounds induced a decrease of cells in G1 and an increase of cells in S 
phase. 1.3-DNP was most potent of the three, as it gave a significant G2 increase even at 
lower concentrations, from 11% in control to 32% and 33% in 3 µM and 10 µM respectively. 
Together with a decrease in G1 phase down from 59% in control to 25% in 10 µM, and S 
phase increase from 27% in control to 42% in 10 µM. 1.8-DNP also show more potent than 1-
NP, it gave a significant decrease of cells in G1 phase, down from 57% in control to 42% at 
10 µM and up from 28% in control to 42% at 10 µM in S phase. 1-NP gave a G1 reduction 
from 57% in control to 34% at 10 µM (Fig 10).  
 
DNA damage 
 
 
DNA damage indicating DNA strand breaks and oxidative damage was investigated using the 
comet assay method. In its traditional form it measures DNA strand-breaks (SSBs) and alkali-
labile sites (ALS), but by including the bacterial formamidopyrimidine DNA N-glycosylase 
(Fpg) one can measure oxidized bases such as 7.8-dihydro-8-oxoguanine (8-oxoG) and 
various ring-opened purines (Collins, Dusinska, et al. 1997; Hansen et al. 2010). Samples 
were both untreated and treated with the lesion-specific endonuclease FPG, which recognizes 
specific lesions and converts them to strand breaks. Hepa1c1c7 cells were treated with 1, 3, 
10 or 30 µM 1-NP, 1.3-DNP or 1.8-DNP, 10 µM B[a]P or DMSO as a control for 24 hrs. 
Treatment without FPG gave no increase in DNA damage, except for B[a]P that was used as a 
positive control (Fig. 11A). After FPG treatment a nice dose response was seen for all the 
compounds. 1-NP > 1.3-DNP > 1.8-DNP was the order of damage potential. 1-NP gave an 
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increase from 4 % in the control to 18 % in the highest concentration, 1.3-DNP from 3 % to 
17 %, and 1.8-DNP increased from 3 % to 12 % (Fig. 11B).  
 
DNA damage response 
 
To investigate the different DNA damage signal pathways that can be triggered by 1.3-DNP 
and 1.8-DNP, we looked at the phosporylation of Chk1, H2AX and p53. Phosphorylation was 
investigated with western analysis, and p53 phosphorylation was also investigated with 
immunocytochemistery using specific antibody coupled with secondary antibody (Flour 
Alexa 488-A, horseradish peroxidase-conjugated goat-anti-rabbit).  
 
Checkpoint Chk 1 is an effector kinase activated by ATR in response to single strand breaks. 
It is important in many response to DNA replication stress and some forms of DNA damage 
(Meuth 2010). Analysis of DNA response with western blotting showed an increase of 
phosporylation of Chk1 after 1.8-DNP exposure. 1.3-DNP gave no response to 
phosphorylation of Chk1 (Fig. 12B).  
 
H2AX will become phosphorylated at serine 139 when double-strand (DSB) is induced in 
mammalian cells. This modified form is termed γ-H2AX, and can be easily identified with 
antibodies as a sensitive indicator of DNA DSB formation (Dickey et al. 2009). In our study, 
H2AX was detected after both exposure to 1.3-DNP and 1.8-DNP. Western blotting analysis 
showed an increase in the amount of phosphorylated protein with a molecular weight and 
antibody binding properties corresponding to γH2AX (i.e. the phosphorylated H2AX), and 
suggest an induction of γH2AX. The amount was increasing with increasing concentration of 
the compounds (Fig. 12A).  
 
p53 is a tumor suppressor protein that is a transcription factor, particularly for genes that 
control progression through cell cycle or that initiate apoptosis. As a regulator of apoptosis it 
can act as an induction component to both the extrinsic and intrinsic pathway (Oda, Arakawa, 
et al. 2000; Tampio et al. 2008; Brady and Attardi 2010; Boehme and Blattner 2009). After 
exposure for 24 hrs, western blotting revealed an increase in phosphorylated p53 with 
exposure to 1.8-DNP. This increase is already seen at 1 µM, whereas increase after 1.3-DNP 
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exposure was only at 10 µM (Fig. 12). Immunocytochemi illustrated further that there was a 
translocation of p53 to the nucleus after 1.8-DNP exposure (Fig 14).  
 
NOXA is a primarily a p53-response gene, but can also be activated in the absence of p53. It 
contributes to apoptosis initiated by p53 or DNA damage (Ploner, Kofler, and Villunger 
2008). NOXA encodes a Bcl-2 homology 3 (BH3). When expressed it localizated to 
mitochondria and interacted with anti-apoptotic Bcl-2 family members, resulting in activation 
of caspase 3 (Oda, Ohki, et al. 2000). When exposed to 1.3-DNP for 24 hrs the apparent 
levels of NOXA decreased with increasing concentration, when analyzed by western blotting. 
In contrast, 1.8-DNP exposure did not show any change in protein level (Fig. 12).  
 
Inhibitor of cell death by pifithrin-α and µ 
 
Pifithrin-α (PFT- α) is a chemical compound known for its ability to suppress p53-mediated 
transactivation. It can protect cells from p53-mediated apoptosis induced by various stimuli, 
by inhibiting both pathways from p53 (Komarova et al. 2003; Strom et al. 2006). Light 
microscopy and fluorescence microscopy analysis after Hoechst 33342 and PT staining 
showed that PFT- α almost completely inhibited 1.3-DNP-induced cell death (Fig. 13A), 
suggesting a p53-mediated apoptosis, since it suppress the transactivation of p53.  
 
Pifithrin-µ (PFT- µ ) inhibits p53 binding to mitochondria by reducing its affinity to anti-
apoptotic proteins Bcl-xl and Bcl-2, but has no effect on p53-dependent transactivation 
(Komarova et al. 2003). Light microscopy and fluorescence microscopy analysis after 
Hoechst 33342 and PI staining suggested rather and increase in of 1.3-DNP induced cell death 
(Fig. 13B). Thus, mitochondrial translocation of p53 seems to be of minor importance.  
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DISCUSSION 
 
1-NP, 1.3-DNP and 1.8-DNP are known to induce tumors in rats, and of the three nitro-PAHs 
1.8-DNP is generally thought to be the one that is the most genotoxic and carcinogenic 
(Imaida et al. 1991; Ohgaki et al. 1984; Takayama et al. 1983). Although BEAS-2B cells are 
lung cells, their response to the toxic effects of nitro-PAHs were not so relevant. While 
Hepa1c1c7 cells did show a metabolism close to what is seen in vivo even as it is a hepatoma 
cell line. In accordance to previous studies we find that 1.8-DNP, which is the most 
carcinogenic compound, caused little cell death. In contrast to the previous study, p53 was 
found to translocate to the nucleus, and we also found an adequate DNA damage response 
suggesting that other parallel cell death pathways are lacking. These possible cell death 
signaling pathways seemed to be activated by 1.3-DNP, in which a smaller p53 response 
seemed to be enough to trigger apoptosis.  
 
The compounds tested induced cell death to various extents in the two different cell lines. In 
BEAS-2B cells only 1-NP resulted in a slight increase in cell death, while in Hepa1c1c7 cells 
also the other two nitro-PAHs; 1.3-DNP and 1.8-DNP, induced cell death. The far most 
cytotoxic of the three compounds was 1.3-DNP. An increased toxicity was observed at 
concentration as low as 3 µM, and as early as between 12 and 20 hrs the cell death started to 
occur. The response after 1.8-DNP exposure was notably smaller than the other two, so after 
further investigation over 72 hrs time course we saw that it did in fact induce cell death.  
 
Cytokines regulates inflammation in two ways, both pro-inflammatory and anti-inflammatory; 
they can also affect tumor development. Acute inflammation after a bacterial or viral infection 
may have beneficial outcome to stop the infection. However, chronic inflammation is often 
harmful and can lead to several diseases including cancer. Also, inflammation after exposure 
to particles does not benefit the cells as the immune system cannot get rid of them. Instead 
this will lead to a chronic state which can result in tissue damage, due to formation of ROS 
and other active metabolites In this study we saw only a cytokine response after 1-NP 
exposure of BEAS-2B cells. Earlier studies have shown a great increase in CXCL8 levels 
after 1-NP (Ovrevik et al. 2010). CXCL8, the cytokine measured, can contribute to human 
cancer progression.  
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It is the caspases that gives apoptotic cells their characteristic appearance of condensed nuclei 
(Bratton and Cohen 2001). Caspase 3, one of the effector caspases, cleaves regulatory 
proteins, including PARP, which is mainly involved in DNA repair and apoptosis 
(Diefenbach and Burkle 2005). In this study we observed that exposure to 1.3-DNP resulted 
in cleaving of both Caspase 3 and PARP. This correlates well with the cell death observed 
with fluorescence microscopy. The necrosis observed with apoptosis after exposure to 1-NP, 
1.3-DNP and 1.8-NP can be due to an incomplete apoptotic process and a switch from 
apoptosis to necrosis, most probably due to inhibition of mitochondrial respiration or 
inactivation of caspases (Nicotera, Leist, and Ferrando-May 1999; Solhaug et al. 2004). When 
mitochondrial respiration is inhibited or disturbed in some way the cells will be ATP depleted, 
as apoptosis is an energy requiring process the cell cannot fully execute it as have to undergo 
another process, necrosis (Leist et al. 1997). An interesting note is that DNA strand breaks 
events results in the activation of PARP. And PARP participates in the repair process of DNA 
but uses nicotinamide adenine dinuclotide (NAD) as a substrate in ADP ribosylation of 
damaged nuclear proteins and DNA, and ADP ribosylation of itself. To maintain the NAD 
stores the cells use ATP, then activation of PARP can contribute to excessive consumption of 
ATP, leading to necrotic cell death (Nanavaty et al. 2002). Our study showed that zVAD-
FMK did partially inhibit 1.3-DNP induced cell death; this supports the need for caspase 
activation in the induced cell death. But as the inhibition was not complete there must be an 
alternative caspase-independent pathway as well. Oxidative damage to mitochondria seems to 
be important for the fate of the cells as mitochondria is not only “the energy production unit” 
of a cell but it is also a key participant in many signal pathways, like the extrinsic apoptotic 
pathway (Fariss et al. 2005). Moderate production of ROS can then lead to the production of 
inflammatory mediators, whereas oxidative stress to high levels of ROS have been shown to 
induce cytotoxicity (Boland et al. 2000).  
 
Earlier work have showed 1.8-DNP to be a more potent mutagen and carcinogen than 1.3-
DNP, however, the damage 1.8-DNP causes is great enough to halter further cell replication 
(Imaida et al. 1991; Takayama et al. 1983). Since 1.8-DNP halts cell cycle it is possible that it 
induces DNA damage that in most cases should result in cell death. One hypotesis is that the 
cells survive the DNA damage, but with an increased probability of having mutations and 
chromosomal aberrations. Abilities like this may contribute to an explanation to the increased 
mutagenic and carcinogenic properties we find in 1.8-DNP (Landvik et al. 2007). In this study 
1.3-DNP and 1.8-DNP were the most potent compounds with regard to cell cycle alterations. 
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1-NP and 1.3-DNP gave a significant accumulation of cells in G2-phase, whereas 1.8-DNP 
gave an increase of cells in S-phase. Large amount of DNA adducts and SSBs, which in turn 
halter DNA replication, can be the reason why the cell cycle is stalled. Previous studies have 
shown a detection of a major DNA adduct after exposure to 1.8-DNP (Landvik et al. 2007). 
Differences in nitroreductases can be one basis for the differences in responses of 
nitropyrenes to DNA adduct formation. 1-NP and 1.3-DNP are reduced by a nitroreductase 
that transfers a single electron, 1.8-DNP, however, is reduced by an enzyme that transfers two 
electrons (Eddy et al. 1986).  
 
To further investigate the damage that could lead to alterations in cell cycle we used the 
comet assay. Previous studies have shown that 1-nitrosopyrene, a metabolite of 1-NP, are 
reduced by NADH and can then produce significant amounts of ROS through cyclic redox 
reactions, resulting in oxidative damage (Cherng et al. 2006). This is verified in our study as 
we detected oxidative damage from exposure with 1-NP, but also from the other two 
compounds, 1.3-DNP and 1.8-DNP. In the present study we showed an increase in SSBs 
when cells were exposed to 1.8-DNP at 30 µM, and a minor increase when exposed to 1.3-
DNP. Oxidative DNA damage, detected as 8-oxoG, was high in all the compounds cells were 
exposed to. This correlates with the finding of accumulation of cells in S-phase that is 
described earlier. DNA damage may activate cell cycle checkpoints and stall replication.  
 
 
PAHs may induce apoptosis resulting from DNA damage, and/or cytotoxic damage (Landvik 
et al. 2007). We wanted to investigate the mechanisms and pathways that exposure to 1.3-
DNP and 1.8-DNP would give, but also to see if there was any difference between the two. 1-
NP has already been more thoroughly investigated and are known to activate a set of different 
signaling pathways. DNA damage can initiate different cell signaling pathways as a response 
to the damage. These include activation of checkpoints to the cell cycle and delay of the cycle 
progression, which will lead to an increase in S-phase, enabling time to repair the damaged 
DNA or induction of cell death. Characterization of signaling routes involved in response to 
DNA damage detection and execution, commonly called the DNA damage response.  
 
In this study, we observed an increase in phosphorylation of H2AX, phosphorylation of serine 
15 at p53, activation of Chk1, NOXA, however gave no marked decrease in 1.8-DNP exposed 
cells. 1.3-DNP gave response in H2AX and a notably activation of p53, however, none in 
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Chk1 and NOXA. There is an indication that points to formation of γH2AX as an early 
chromatin modification following initiation of DNA fragmentation during apoptosis 
(Rogakou et al. 2000). This finding is interesting as 1.8-DNP only gave cell death after longer 
exposure. p53 may trigger apoptosis, and expression of several different apoptotic genes 
involved in the mitochondrial apoptotic pathway are stimulated by p53 (Meek 2004). BCL-2 
family proteins regulate the release of cytochrome c from mitochondria and the following 
activation of caspases. 
 
p53 inhibition with pifithin-α (PFT- α) did show a full inhibition of cell death induced by 1.3-
DNP. PFT- α does inhibit nuclear accumulation of p53. This correlates with p53 being 
involved in the 1.3-DNP-induced cell death, and that the nuclear translocation and the 
following transciption is playing a central role in the apoptotic pathway. Pifithrin-µ (PFT-µ) 
gave no decrease in inhibition of cell death, suggesting that translocation of p53 to the nucleus 
is not needed to execute the apoptotic prcess (Komarova et al. 2003). This supports our 
findings from the immunocytochemistery that the phosphorylated p53 accumulates in the 
nucleus, and hence implies a transactivation of p53.  
 
Immunocytochemistery showed no translocation of p-p53 after 1.3-DNP exposure but after 
1.8-DNP exposure a translocation was seen. This implies that there have to be some kind of 
inhibition of the death signal further down the signal pathway, as the cells do not die.  
 
Treatment to 1-NP did show a formation of vacuoles as described earlier by (Asare et al. 
2009). In the present study, a difference in the cellular effects the PAHs caused was seen. 
Different number of nitro amines and also their configuration seem to have an important 
significance in how they affect the cells. The reason for this could be that they interact with 
different enzymes, or that the affinity for the same enzyme is higher or lower. It is therefore 
interesting to see that there is such a dramatic difference regarding the cytotoxicisity between 
1.3-DNP and 1.8-DNP.  
 
As conclusion, the study showed that the different nitro-PAHs had very different toxic 
potential (cell death), and that a small change in molecular structure, such as a substitution 
from 3
rd
 position to 8
th
 position can have such a massive impact to the cellular response. Most 
interesting were that 1.8-DNP induced low cytotoxcicity, while it still had almost the same 
level of DNA damage as the rest of the compounds tested. The DDR is activated, represented 
57 
 
by Chk1 and p53, suggesting that other parallel pathways may be lacking. In contrast to a 
previous study, p53 was found to translocate to the nucleus. 1.3-DNP, however, seemed to 
activate the cell death signaling pathway, but the amount of p53 response required to trigger 
apoptosis seemed smaller. 
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FIGURE LEGENDS 
 
Figure 1. Chemical structures of the test compounds.  
 
 
Figure 2. Morphology changes determined by light microscopy. BEAS-2B cells were 
exposed to 1, 5, 10, 15 or 30 µM 1-NP, 1.3-DNP or 1.8-DNP, for 24hrs. Control cells were 
treated with DMSO only. Original magnification; 100X, examined by reverted microscope.  
 
 
Figure 3. Morphology changes determined by light microscopy. Hepa1c1c7 cells were 
exposed to 1, 3, 10 or 30 µM 1.3-DNP or 1.8-DNP, for 24hrs. Control cells were treated with 
DMSO only. Original magnification; 100X, examined by reverted microscope.  
 
 
Figure 4. Morphology changes determined by fluorescence microscopy. Both BEAS-2B 
and Hepa1c1c7 cells were treated with 1-NP, 1.3-DNP, 1.8-DNP or DMSO (control), for 24 
hrs. Concentration was 30 µM. The cells are stained with Hoechst 33342 and propidium 
iodide (PI). Hoechst stains nucleus and DNA appear fluorescent blue. Hoechst can penetrate 
the cell membrane. PI is a red fluorescent dye. It can only stain cells with a disrupted 
membrane. V: viable cells. Nec: necrotic cells. Ap: apoptotic cells. Ap/Nec: apoptotic-
necrotic cells. Original magnification; 400X?.  
 
 
Figure 5. Cell death determined by fluorescence microscopy. BEAS-2B cells were 
exposed to 1-NP, 1.3-DNP, 1.8-DNP or DMSO (control), for 24 hrs. The concentration was 1, 
5, 10, 15 or 30 µM. Cells were exposed and trypsinated, stained with Hoechst 33342 and 
propidium iodide (PI), and subsequently analyzed for apoptosis, necrosis and 
apoptosis/necrosis using fluorescence microscopy. The data presents mean ±SEM of 
independent experiments (n=5). No significant difference from DMSO-treated controls.  
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Figure 6. Cell death determined by fluorescence microscopy. Hepa1c1c7 cells were 
exposed to 1-NP, 1.3-DNP, 1.8-DNP or DMSO (control), for 24 hrs. The concentration was 1, 
3, 10 or 30 µM. Cells were exposed and trypsinated, stained with Hoechst 33342 and 
propidium iodide (PI), and subsequently analyzed for apoptosis, necrosis and 
apoptosis/necrosis using fluorescence microscopy. The data presents mean ±SEM of 
independent experiments (n=3). * Significantly different from DMSO-treated controls.  
 
 
Figure 7. Celle death determined by fluorescence microscopy. A) Hepa1c1c7 cells were 
exposed to 1.3-DNP or DMSO (control), for 24 hrs. The concentration was 1, 3, 10 or 30 µM. 
Cells were harvested after 0, 8, 12, 20 or 24 hrs. B) Cells were exposed to 1.8-DNP or DMSO 
(control) and harvested after 72 hrs. Cells were exposed and trypsinated, stained with Hoechst 
33342 and propidium iodide (PI), and subsequently analyzed for apoptosis, necrosis and 
apoptosis/necrosis using fluorescence microscopy. The data presents mean ±SEM of 
independent experiments (n=3). * Significantly different from DMSO-treated controls.  
 
 
Figure 8. IL-8 determined by ELISA. A) BEAS-2B cells were exposed to 1, 5, 10, 15, or 30 
µM of 1-NP, 1.3-DNP or 1.8-DNP or DMSO for 24 hrs, and the media were subsequently 
analyzed. The data presents mean ±SEM of independent experiments (n=5). B) 
 
 
Figure 9. Effects of PAHs on caspase 3 and PARP, determined by Western blotting, and 
inhibition of apoptosis by zVAD-FMK. In Hepa1c1c7 cells (A) Levels of PARP and 
caspase 3 were analyzed by Western blotting, after 24 hrs of exposure of various levels of 1.3-
DNP, 1.8-DNP or DMSO. Picture is one out of three independent experiments. (B) 
Microscopic examination, following PI/Hoechst 33342 staining, of the effect of the caspase 
inhibitor zVAD-FMK on 1.3-DNP induced cell death (apoptosis and necrosis). The 
Hepa1c1c7 cells were pre-treated for 1 h with zVAD-FMK ( µM) followed by co-exposure of 
1.3-DNP (30 µM) or DMSO, for 24 hrs. Percentage of cell death was estimated by 
fluorescence microscopy counts. The data presents mean ±SEM of independent experiments 
(n=3). * Significantly different from DMSO-treated controls. # Significantly different from 
treatment without zVAD-FMK. 
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Figure 10. Celle cycle distributions measured by flow cytometri. Hepa1c1c7 cells were 
exposed to 1-NP, 1.3-DNP, 1.8-DNP or DMSO (control), for 24 hrs. The concentration was 
0.1, 0.3, 1 or 3 µM. Cells were trypsinated and stained with Hoechst 33258. Data is presented 
as the relative proportions of cells (%) in the different cell cycle phases. Each bar represents 
mean ± SEM of independent experiments. (n=3). * Significantly different from DMSO-
treated controls (p < 0.05). 
 
 
Figure  11. DNA damage measured by comet assay. Illustration of cells with different 
amount of tail intensity (A). Hepa1c1c7 cells were exposed to 1, 3, 10 or 30 µM of 1-NP, 1.3-
DNP, 1.8-DNP, B[a]P or DMSO, for 24 hrs. DNA strand breaks were measured without 
enzyme treatment (B), and oxidative damage to DNA was measured after treatment with FPG 
enzyme (C). Values (% tail DNA) represent mean ± SEM of independent experiments (n=3).  
 
 
Figure 12. Effects of PAHs on histone H2AX, Chk1, phosphorylated p53 and NOXA, 
determined by Western blotting. In Hepa1c1c7 cells: (A) Levels of phosphorylated H2AX 
(γH2AX) were analyzed by Western blotting after 24 hrs of exposure to various 
concentrations of 1.3-DNP, 1.8-DNP or DMSO. The picture is representative for one out of 
three separate experimental set-ups. (B) Levels of p-Chk1 after exposure to the PAHs for 24 
hrs (C) Levels of phosphorylated p53 after exposure to the PAHs for 24 hrs. (D) Levels of 
NOXA after exposure to 1.3-DNP and 1.8-DNP for 24 hrs.   
 
 
Figure 13. 1.3-DNP induced p53 activation and involvement if cell death, determined by 
fluorescence microscopy. In Hepa1c1c7 cells: (A) Cells were exposed to 10 µM 1.3-DNP for 
24 hrs with or without pre-incubation for 1 h with pifithrin- α (PFT-α, 20 µM). Control cells 
were treated with DMSO only. (B) Cells were exposed to 10 µM 1.3-DNP for 24 hrs with or 
without pre-incubation for 1 h with pifithrin- µ (PFT-µ, 20 µM). Control cells were treated 
with DMSO only. * Significantly different from DMSO-treated controls. # Significantly 
different from treatment without inhibitor. 
 
Figure 14. Effects on phosphorylated p53 determined by immunocytochemistery. In 
Hepa1c1c7 cells subcellular location of phosphorylated p53 was analyzed by 
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immunocytochemistery after 24 hrs of exposure to 30 µM of 1.3-DNP and 1.8-DNP. The 
picture is only acquired from one experimental set up. Original magnification; 1000X. 
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